Clinical trial
The Effect of Glucagon on Cerebral Glucose Metabolism in Healthy Humans
NCT06877208 is registered in ClinicalTrials.gov with Nicolai Jacob Wewer Albrechtsen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of Glucagon on Cerebral Glucose Metabolism in Healthy Humans
- Lead sponsor
- Nicolai Jacob Wewer Albrechtsen
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- March 18, 2025
- Completion date
- August 31, 2027
- Enrollment
- 12 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cerebral glucose metabolism